PATENT CLAIM ANALYSIS

Application Number: 15756407
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "019300"]

Abstract:
This disclosure provides compositions and methods for treating or preventing cardiac or vascular toxicity in a subject receiving a chemotherapeutic agent, where the cardiac or vascular toxicity is associated with administration of the chemotherapeutic agent. Also provided are compositions and methods for treating or preventing endothelial dysfunction and for modulating endothelial function and oxidative stress.

Claim (Index 5):
An isolated peptide comprising a non-phosphorylatable substitution relative to the serine residue at position 6 of SEQ ID NO:1, wherein said isolated peptide is less than 20 amino acids, comprises an amino acid sequence at least 80% homologous to the sequence as set forth by SEQ ID NO:1, and is capable of preventing TERT nuclear translocation.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 1.56757
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12528465', '14243923', '15022280', '10148457', '12162135']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7299880407179605
- 35 USC 102 Novelty (BERT): 0.5196992425628438
- Combined Prediction Score: 0.7089591609024488
- Mean Citation Score: 278.669534
- Max Citation Score: 292.4309
- Similarity Product: 205.5809298269868

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test